|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 147.3 USD | -0.81% |
|
+0.86% | -6.21% |
| 02:19pm | Redburn Atlantic Adjusts Johnson & Johnson Price Target to $160 From $170 | MT |
| Apr. 24 | Cidara Therapeutics Shares Surge 42% After Re-Acquiring Flu Asset | DJ |
Johnson & Johnson reported earnings results for the full year ended January 02, 2022. For the full year, the company reported sales was USD 93,775 million compared to USD 82,584 million a year ago. Net income was USD 20,878 million compared to USD 14,714 million a year ago.
Diluted earnings per share from continuing operations was USD 7.81 compared to USD 5.51 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -6.21% | 358B | |
| +24.17% | 562B | |
| +20.17% | 322B | |
| +8.06% | 297B | |
| +13.45% | 219B | |
| +6.04% | 199B | |
| -10.51% | 196B | |
| -11.48% | 149B | |
| -6.32% | 146B | |
| +2.07% | 117B |
JOHNSON & JOHNSON 
